Report Detail

Pharma & Healthcare Global Lung Cancer Diagnostic Tests Market Research Report 2019

  • RnM2744860
  • |
  • 11 April, 2019
  • |
  • Global
  • |
  • 105 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Lung Cancer Diagnostic Tests market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Lung Cancer Diagnostic Tests volume and value at global level, regional level and company level. From a global perspective, this report represents overall Lung Cancer Diagnostic Tests market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville Bioscience, Inc.
Mayo Clinic US

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods

Segment by Application
Precision Medicine
Personalized Medicine
Cancer Monitoring


Table of Contents

    Executive Summary

      1 Lung Cancer Diagnostic Tests Market Overview

      • 1.1 Product Overview and Scope of Lung Cancer Diagnostic Tests
      • 1.2 Lung Cancer Diagnostic Tests Segment by Type
        • 1.2.1 Global Lung Cancer Diagnostic Tests Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Immunoassays
        • 1.2.3 Flow Cytometry
        • 1.2.4 Rapid Tests
        • 1.2.5 Molecular Assays
        • 1.2.6 Tissue Arrays
        • 1.2.7 Circulating Tumor Cells
        • 1.2.8 Pharmacodiagnostics
        • 1.2.9 Biomarkers
        • 1.2.10 Other Diagnostics Methods
      • 1.3 Lung Cancer Diagnostic Tests Segment by Application
        • 1.3.1 Lung Cancer Diagnostic Tests Consumption Comparison by Application (2014-2025)
        • 1.3.2 Precision Medicine
        • 1.3.3 Personalized Medicine
        • 1.3.4 Cancer Monitoring
      • 1.3 Global Lung Cancer Diagnostic Tests Market by Region
        • 1.3.1 Global Lung Cancer Diagnostic Tests Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Lung Cancer Diagnostic Tests Market Size
        • 1.4.1 Global Lung Cancer Diagnostic Tests Revenue (2014-2025)
        • 1.4.2 Global Lung Cancer Diagnostic Tests Production (2014-2025)

      2 Global Lung Cancer Diagnostic Tests Market Competition by Manufacturers

      • 2.1 Global Lung Cancer Diagnostic Tests Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Lung Cancer Diagnostic Tests Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Lung Cancer Diagnostic Tests Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Lung Cancer Diagnostic Tests Production Sites, Area Served, Product Types
      • 2.5 Lung Cancer Diagnostic Tests Market Competitive Situation and Trends
        • 2.5.1 Lung Cancer Diagnostic Tests Market Concentration Rate
        • 2.5.2 Lung Cancer Diagnostic Tests Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Lung Cancer Diagnostic Tests Production Market Share by Regions

      • 3.1 Global Lung Cancer Diagnostic Tests Production Market Share by Regions
      • 3.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Lung Cancer Diagnostic Tests Production
        • 3.4.1 North America Lung Cancer Diagnostic Tests Production Growth Rate (2014-2019)
        • 3.4.2 North America Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Lung Cancer Diagnostic Tests Production
        • 3.5.1 Europe Lung Cancer Diagnostic Tests Production Growth Rate (2014-2019)
        • 3.5.2 Europe Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Lung Cancer Diagnostic Tests Production (2014-2019)
        • 3.6.1 China Lung Cancer Diagnostic Tests Production Growth Rate (2014-2019)
        • 3.6.2 China Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Lung Cancer Diagnostic Tests Production (2014-2019)
        • 3.7.1 Japan Lung Cancer Diagnostic Tests Production Growth Rate (2014-2019)
        • 3.7.2 Japan Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Lung Cancer Diagnostic Tests Consumption by Regions

      • 4.1 Global Lung Cancer Diagnostic Tests Consumption by Regions
      • 4.2 North America Lung Cancer Diagnostic Tests Consumption (2014-2019)
      • 4.3 Europe Lung Cancer Diagnostic Tests Consumption (2014-2019)
      • 4.4 China Lung Cancer Diagnostic Tests Consumption (2014-2019)
      • 4.5 Japan Lung Cancer Diagnostic Tests Consumption (2014-2019)

      5 Global Lung Cancer Diagnostic Tests Production, Revenue, Price Trend by Type

      • 5.1 Global Lung Cancer Diagnostic Tests Production Market Share by Type (2014-2019)
      • 5.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Type (2014-2019)
      • 5.3 Global Lung Cancer Diagnostic Tests Price by Type (2014-2019)
      • 5.4 Global Lung Cancer Diagnostic Tests Production Growth by Type (2014-2019)

      6 Global Lung Cancer Diagnostic Tests Market Analysis by Applications

      • 6.1 Global Lung Cancer Diagnostic Tests Consumption Market Share by Application (2014-2019)
      • 6.2 Global Lung Cancer Diagnostic Tests Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Lung Cancer Diagnostic Tests Business

      • 7.1 Advpharma Inc
        • 7.1.1 Advpharma Inc Lung Cancer Diagnostic Tests Production Sites and Area Served
        • 7.1.2 Lung Cancer Diagnostic Tests Product Introduction, Application and Specification
        • 7.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 AIT Austrian Institute of Technology GmbH
        • 7.2.1 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Production Sites and Area Served
        • 7.2.2 Lung Cancer Diagnostic Tests Product Introduction, Application and Specification
        • 7.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Courtagen Life Sciences Inc
        • 7.3.1 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Production Sites and Area Served
        • 7.3.2 Lung Cancer Diagnostic Tests Product Introduction, Application and Specification
        • 7.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 DiagnoCure Inc. (Inactive)
        • 7.4.1 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Production Sites and Area Served
        • 7.4.2 Lung Cancer Diagnostic Tests Product Introduction, Application and Specification
        • 7.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 BioMark Diagnostics Inc.
        • 7.5.1 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Production Sites and Area Served
        • 7.5.2 Lung Cancer Diagnostic Tests Product Introduction, Application and Specification
        • 7.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 BioMarker Strategies LLC
        • 7.6.1 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Production Sites and Area Served
        • 7.6.2 Lung Cancer Diagnostic Tests Product Introduction, Application and Specification
        • 7.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Emory University
        • 7.7.1 Emory University Lung Cancer Diagnostic Tests Production Sites and Area Served
        • 7.7.2 Lung Cancer Diagnostic Tests Product Introduction, Application and Specification
        • 7.7.3 Emory University Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Epigenomics AG
        • 7.8.1 Epigenomics AG Lung Cancer Diagnostic Tests Production Sites and Area Served
        • 7.8.2 Lung Cancer Diagnostic Tests Product Introduction, Application and Specification
        • 7.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 GlycoZym
        • 7.9.1 GlycoZym Lung Cancer Diagnostic Tests Production Sites and Area Served
        • 7.9.2 Lung Cancer Diagnostic Tests Product Introduction, Application and Specification
        • 7.9.3 GlycoZym Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 HalioDx SAS
        • 7.10.1 HalioDx SAS Lung Cancer Diagnostic Tests Production Sites and Area Served
        • 7.10.2 Lung Cancer Diagnostic Tests Product Introduction, Application and Specification
        • 7.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Louisville Bioscience, Inc.
      • 7.12 Mayo Clinic US

      8 Lung Cancer Diagnostic Tests Manufacturing Cost Analysis

      • 8.1 Lung Cancer Diagnostic Tests Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Lung Cancer Diagnostic Tests
      • 8.4 Lung Cancer Diagnostic Tests Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Lung Cancer Diagnostic Tests Distributors List
      • 9.3 Lung Cancer Diagnostic Tests Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Lung Cancer Diagnostic Tests Market Forecast

      • 11.1 Global Lung Cancer Diagnostic Tests Production, Revenue Forecast
        • 11.1.1 Global Lung Cancer Diagnostic Tests Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Lung Cancer Diagnostic Tests Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Lung Cancer Diagnostic Tests Price and Trend Forecast (2019-2025)
      • 11.2 Global Lung Cancer Diagnostic Tests Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Lung Cancer Diagnostic Tests Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Lung Cancer Diagnostic Tests Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Lung Cancer Diagnostic Tests Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Lung Cancer Diagnostic Tests Production, Revenue Forecast (2019-2025)
      • 11.3 Global Lung Cancer Diagnostic Tests Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Lung Cancer Diagnostic Tests Consumption Forecast (2019-2025)
        • 11.3.2 Europe Lung Cancer Diagnostic Tests Consumption Forecast (2019-2025)
        • 11.3.3 China Lung Cancer Diagnostic Tests Consumption Forecast (2019-2025)
        • 11.3.4 Japan Lung Cancer Diagnostic Tests Consumption Forecast (2019-2025)
      • 11.4 Global Lung Cancer Diagnostic Tests Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Lung Cancer Diagnostic Tests Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Lung Cancer Diagnostic Tests . Industry analysis & Market Report on Lung Cancer Diagnostic Tests is a syndicated market report, published as Global Lung Cancer Diagnostic Tests Market Research Report 2019. It is complete Research Study and Industry Analysis of Lung Cancer Diagnostic Tests market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $4,350.00
        $5,800.00
        2,311.30
        3,466.95
        4,622.60
        2,694.10
        4,041.15
        5,388.20
        444,367.00
        666,550.50
        888,734.00
        241,976.00
        362,964.00
        483,952.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report